Author

B. Neel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:differential expression· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Hata· 1 shared A. Hussain· 1 shared A. Lopez· 1 shared B. Clarke· 1 shared C. M. Dowling· 1 shared C. M. Rudin· 1 shared C. Richman· 1 shared D. Fenyo· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hata

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1-mutant lung cancer

J. Deng, D. H. Peng, D. Fenyo, Y. Hao, A. Lopez, D. Levin, M. Meynardie, M. Quinteros, M. Ranieri, S. Sahu, S. Lau, E. Shum, V. Velcheti, S. R. Punekar, N. Rekhtman, , K.-K. Wong

The paper identifies CD38 as a therapeutic target in LKB1-mutant lung cancer through in vivo metabolomics and shows that targeting CD38 inhibits tumor growth.

bioRxiv · Apr 18, 2023 · PreprintCancer Biology

Distinct cancer-associated fibroblast states drive clinical outcomes in high-grade serous ovarian cancer and are regulated by TCF21

A. Hussain, V. Voisin, S. Poon, J. Dmytryshyn, C. Richman, J. Meens, V. W. Ho, K. H. Tang, J. Paterson, B. Clarke, M. Bernardini, G. Bader, B. Neel, L. Ailles

This study identifies two distinct cancer-associated fibroblast subtypes in high-grade serous ovarian cancer and shows their differential impact on patient outcomes and tumor progression.

bioRxiv · May 10, 2019Cancer Biology

Activated thiol Sepharose-based proteomic approach to globally quantify protein oxidation

Y. Xu, B. Neel

The paper develops a redox proteomics method to globally quantify protein oxidation, showing its application in HLRCC cells and demonstrating its utility in analyzing redox signaling.

bioRxiv · Feb 14, 2019Biochemistry